Meteorin-β Activity Assays Using Cytokine and Receptor Binding Readouts

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack effective ways to detect the activity of meteorin-β and identify cells expressing its receptor, which are crucial for research and therapeutic applications.

Innovation Solution

Methods are developed to assess meteorin-β activity by measuring cytokine and chemokine production in response to meteorin-β stimulation and to identify receptor expression through binding assays, using kits containing co-stimulants like IFN-γ, IL-4, and TGFβ, along with components for measuring cytokine production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Difficulty of detecting and measuring

If no specific detection method is used, then the complexity of the system remains low, but the ability to detect meteorin-β activity and receptor expression is insufficient

Engineering Contradiction:
Improvedetection capabilityVSAvoidsystem complexity
Core Design Contradiction:
Difficulty of detecting and measuringVSDevice complexity

Solution Approach 1:

The detection system is divided into separate functional modules: co-stimulant composition (IFN-γ, IL-4, TGFβ), meteorin-β polypeptide, cytokine/chemokine measurement components, and binding assay components. This segmentation allows each module to perform a specific function, improving detection capability while keeping individual components manageable and the overall system organized.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The detection method uses a multi-functional assay system that can detect both meteorin-β activity (through cytokine/chemokine production measurement) and receptor expression (through binding assays) using the same cell-based platform. This universal approach enhances detection capability across multiple parameters without requiring entirely separate systems.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If simple measurement methods are used, then the ease of operation is high, but the measurement precision of cytokine production and receptor binding is insufficient

Engineering Contradiction:
Improvecytokine production measurement accuracyVSAvoidoperational simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The system uses co-stimulants (IFN-γ, IL-4, TGFβ) as intermediary substances that enhance and standardize the cellular response to meteorin-β stimulation. These intermediaries amplify the cytokine production signal, improving measurement precision while providing a controlled and reproducible assay protocol that maintains ease of operation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The detection method measures cytokine and chemokine production levels as feedback signals that directly indicate meteorin-β activity and receptor expression. This quantitative feedback mechanism enables precise measurement while the standardized assay protocol ensures the feedback is obtained through simple, repeatable operational steps.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These methods provide accurate assessment of meteorin-β activity and receptor expression, enabling better research and therapeutic applications, such as immunotherapy.

Implementation Method 1

contacting the cell under binding conditions with a second composition comprising a meteorin-β polypeptide; detecting the presence, absence, and/or amount of meteorin-β polypeptide bound to the cell

Methodology Applied
Scientific EffectReceptor-ligand binding:

Implementation Method 2

measuring production by the cell of one or more cytokines and/or chemokines chosen from CCL2, CCL5, CXCL1, CXCL8, CXCL9, CXCL10, IL-6 and IL-1RA

Methodology Applied
Scientific EffectCytokine production:

Data Source

PatentUS20260043811A1Methods for detecting meteorin-beta activity
Publication Date: 2026.02.12 BIOLEGEND INC
  • US20260043811A1 patent drawing
  • US20260043811A1 patent drawing
  • US20260043811A1 patent drawing

AI summary

The technology relates in part to methods for detecting the activity of Meteorin-β and modified versions thereof.